Development of 2,2-dimethylchromanol cysteinyl LT1 receptor antagonists
摘要:
A new series of cysLT(1) receptor antagonists represented by CP-288,886 (7) and CP-265,298 (8) were developed which are equipotent to clinical cysLT(1) receptor antagonists Zafirlukast (1) and Pranlukast (2). (C) 1998 Elsevier Science Ltd. All rights reserved.
A new series of cysLT(1) receptor antagonists represented by CP-288,886 (7) and CP-265,298 (8) were developed which are equipotent to clinical cysLT(1) receptor antagonists Zafirlukast (1) and Pranlukast (2). (C) 1998 Elsevier Science Ltd. All rights reserved.